Angie Craig actually said...

The burden of high out-of-pocket costs of drugs on Medicare beneficiaries is significant.

It is clear that lowering costs for seniors will not only improve their lives, but research has shown that for thousands of people each year...

One study found that if Medicare is able to negotiate, lower drug prices and cost-sharing responsibilities for beneficiaries are reduced.

Long COVID is such a complex disease that we don't know so much about it at this point.